Abstracts

DISCOVERY AND DEVELOPMENT OF HIV BROADLY NEUTRALIZING ANTIBODIES

Combination antiretroviral therapy (ART) has revolutionized the treatment and prevention of HIV-1 infection. Taken daily, ART prevents and suppresses the infection. However, ART interruption almost invariably leads to rebound viremia in infected individuals due to a long-lived latent reservoir of integrated proviruses. Therefore, ART must be administered on a life-long basis. The lecture will focus…

UPDATE ON HIV IMMUNOLOGY

Dr Moore will describe advances in eliciting protective antibodies by vaccination, highlight emerging insights at the interface between innate and adaptive immunity, and summarize key new immunological findings at CROI. Please see the session overview for the Program Committee Workshop for New Investigators and Trainees for a description of the session.  

UPDATE ON HIV PREVENTION

Dr Hillier will describe the current landscape of biomedical HIV prevention research including vaccines, broadly neutralizing antibodies, oral and injectable pre-exposure prophylaxis, vaginal and rectal microbicides, and combination approaches for prevention of HIV. Please see the session overview for the Program Committee Workshop for New Investigators and Trainees for a description of the session.  

TRANSITIONING TO NEW GENERIC ANTIRETROVIRALS IN SUB-SAHARAN AFRICA

The pricing of drugs has influenced national ARV treatment guidelines in many Sub Saharan countries. The new possibility of integrase inhibitors – mostly dolutegravir (DTG) as first line was becoming a reality. This development called for policy adoption and introduction into national treatment guidelines, planning for roll-out, streamlining, and strengthening supply chain systems; all in…

GLOBAL ELIMINATION OF HEPATITIS C

With the remarkable advances in therapy for hepatitis C virus (HCV) infection, almost all infected individuals can now be cured with short-course, well-tolerated therapy. The success of current treatment has raised the prospect that perhaps this chronic infection could actually be eliminated as a public health threat on a global scale. With this in mind,…

THE RISING CHALLENGE OF LIVER CANCER

In 2015 there have been 854,000 incident cases of liver cancer and 810,000 related deaths globally contributing to > 20 million disability-adjusted life-years (DALYs).Incident liver cancer increased by 75% between 1990-2015 : 47% explained by changing population age structures, 35% by population growth and 8% to changing age-specific incidence rates. Infection with the hepatitis B…